By Aduragbemi Omiyale GlaxoSmithKline Consumer Nigeria (GSK) Plc has commenced the payment of the approved N17.42 per share to minority shareholders as part of
By Dipo Olowookere The entire shares of GlaxoSmithKline (GSK) Consumer Nigeria Plc have been delisted from the Nigerian Exchange (NGX) Limited. The equities of
By Dipo Olowookere The Securities and Exchange Commission (SEC) has granted the request of GlaxoSmithKline (GSK) Consumer Nigeria Plc to leave the Nigerian Exchange
By Precious Olisa The Lagos Chamber of Commerce and Industry (LCCI) and the Nigeria Employers’ Consultative Association (NECA) have expressed their disappointment over the
By Aduragbemi Omiyale A British pharmaceutical company, GlaxoSmithKline (GSK) UK Group, intends to close its operations in Nigeria and then exit the Nigerian Exchange
By Dipo Olowookere GlaxoSmithKline (GSK) Consumer Nigeria Plc has released its financial statements for the first quarter of 2020, recording a flat topline. The